5 September 2024 - NICE has recommended belzutifan for some adults with von Hippel-Lindau disease, in final draft guidance, which could ...
4 September 2024 - NICE has published final evidence-based recommendations on the use of zanubrutinib (Brukinsa) for the treatment of ...
29 August 2024 - NICE has published final evidence-based recommendations on the use of pembrolizumab (Keytruda) in combination with platinum- ...
14 August 2024 - NICE has published final evidence-based recommendations on the use of relugolix (Orgovyx) for the treatment of ...
9 August 2024 - We’ve recommended 2 new treatments for multiple myeloma, an incurable blood cancer that affects bone marrow, ...
8 August 2024 - NICE is unable to make a recommendation about the use in the NHS of enzalutamide for the ...
30 July 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
1 August 2024 - A take at home tablet which could be a ‘game-changer’ for hundreds of blood cancer patients ...
29 July 2024 - Daiichi Sankyo and partner company AstraZeneca have been unwilling to offer a price that would enable NICE ...
19 July 2024 - A new pill to treat advanced hormone sensitive prostate cancer that could benefit just over 40,000 ...
8 July 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the ...
16 July 2024 - The Department of Health and Social Care has asked the NICE to review the guidance on ...
12 July 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
11 July 2024 - Project Orbis is a global initiative that aims to streamline regulatory review processes across international regulators in ...
10 July 2024 - NICE is unable to make a recommendation about the use in the NHS of lisocabtagene maraleucel (Breyanzi) ...